Renal replacement therapy in congestive heart failure requiring left ventricular assist device augmentation

Peritoneal Dialysis International

Volumn 32, Issue 4, 2012, Pages 386-392

  Thomas, Bernadette A ^a   Logar, Christine M ^a   Anderson, Arthur E ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Bacteremia; Cardiorenal syndrome; Hemodialysis; LVAD

Indexed keywords

CREATININE; GENTAMICIN; LOOP DIURETIC AGENT; NITROGEN; UREA;

ACUTE KIDNEY FAILURE; ADULT; AORTA BALLOON; APPLICATION SITE INFECTION; CARDIORENAL SYNDROME; CASE REPORT; CONGESTIVE HEART FAILURE; DISEASE EXACERBATION; DISEASE SEVERITY; DIURESIS; DYSPNEA; ECHOCARDIOGRAPHY; HEART EJECTION FRACTION; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; LEFT VENTRICULAR ASSIST DEVICE; MALE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; REVIEW; THROMBOEMBOLISM; UREA NITROGEN BLOOD LEVEL; UREMIA;

CARDIO-RENAL SYNDROME; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; RENAL DIALYSIS; RENAL INSUFFICIENCY; RENAL REPLACEMENT THERAPY;

EID: 84864678868     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2011.00076     Document Type: Review

References (22)

1. Roger VL. The heart failure epidemic. Int j Environ Res Public Health 2010; 7:1807-1830.
2. Ronco C, McCullough P, Anker SD, Anand I, Aspromonte N, Bagshaw SM, et al. on behalf of the Acute Dialysis Quality Initiative (ADQI) consensus group. Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart j 2010; 31:703-711.
3. Argenziano M, Catanese KA, Moazami N, Gardocki MT, Weinberg AD, Clavenna MW, et al. The influence of infection on survival and successful transplantation in patients with left ventricular assist devices. j Heart lung Transplant 1997; 16:822-831.
4. Birks EJ, Yacoub MH, Banner NR, Khaghani A. The role of bridge to transplantation: should LVAD patients be transplanted? Curr opin Cardiol 2004; 19:148-153.
5. Fischer SA, Trenholme GM, Costanzo MR, Piccione W. Infectious complications in left ventricular assist device recipients. Clin Infect Dis 1997; 24:18-23.
6. Gordon SM, Schmitt SK, Jacobs M, Smedira NM, Goormastic M, Banbury MK, et al. Nosocomial bloodstream infections in patients with implantable left ventricular assist devices. Ann Thorac Surg 2001; 72:725-730.
7. Malani PN, Dyke DB, Pagani FD, Chenoweth CE. Nosocomial infections in left ventricular assist device recipients. Clin Infect Dis 2002; 34:1295-1300.
8. Krishnan A, Oreopoulos DG. Peritoneal dialysis in congestive heart failure. Adv Perit Dial 2007; 23:82-89.
9. Stack AG, Molony DA, Rahman NS, Dosekun A, Murthy B. Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States. Kidney Int 2003; 64:1071-1079.
10. Vonesh EF, Snyder JJ, Foley RN, Collins AJ. The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int 2004; 66:2389-2401.
11. Mehrotra R, Chiu YW, Kalantar-Zadeh K, Bargman J, Vonesh E. Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Arch Intern Med 2011; 171:110-118.
12. Trespalacios FC, Taylor AJ, Agodoa LY, Bakris GL, Abbott KC. Heart failure as a cause for hospitalization in chronic dialysis patients. Am j Kidney Dis 2003; 41:1267-1277.
13. John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L. Improved survival and decreasing incidence of adverse events with the Heart Mate II left ventricular assist device as bridge-to-transplant therapy. Ann Thorac Surg 2008; 86:1227-1235.
14. Komoda T, Drews T, Hetzer R, Lehmkuhl HB. New prioritization of heart transplant candidates on mechanical circulatory support in an era of severe donor shortage. j Heart lung Transplant 2010; 29:989-996.
15. Sasaoka T, Kato TS, Komamura K, Takahashi A, Nakajima I, Oda N, et al. Improved long-term performance of pulsatile extracorporeal left ventricular assist device. j Cardiol 2010; 56:220-228.
16. Weijmer MC, Vervloet MG, ter Wee PM. Compared to tunnelled cuffed haemodialysis catheters, temporary untun-nelled catheters are associated with more complications already within 2 weeks of use. Nephrol Dial Transplant 2004; 19:670-677.
17. Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Ishani A, et al. US Renal Data System 2010 Annual Data Report. Am j Kidney Dis 2011; 57(Suppl 1):A8,e1-e526.
18. Ishani A, Collins AJ, Herzog CA, Foley RN. Septice-mia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 study. Kidney Int 2005; 68:311-318.
19. Aslam N, Bernardini J, Fried L, Burr R, Piraino B. Comparison of infectious complications between incident hemodialysis and peritoneal dialysis patients. Clin j Am Soc Nephrol 2006; 1:1226-1233.
20. Chavers BM, Solid CA, Gilbertson DT, Collins AJ. Infection-related hospitalization rates in pediatric versus adult patients with end-stage renal disease in the United States. j Am Soc Nephrol 2007; 18:952-959.
21. Grothe C, da Silva Belasco AG, de Cássia Bittencourt AR, Vianna LA, de Castro Cintra Sesso R, Barbosa DA. Incidence of bloodstream infection among patients on hemodialysis by central venous catheter. Rev lat Am Enfermagem 2010; 18:73-80.
22. Morduchowicz G, van Dyk DJ, Wittenberg C, Winkler J, Boner G. Bacteremia complicating peritonitis in peritoneal dialysis patients. Am j Nephrol 1993; 13:278-280.